Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis

NCT01785875 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01785875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01785875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2013
Completion date
July 1, 2015
Enrollment
891 (actual)
Sites
208

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, secondary